Asston Pharmaceuticals IPO Allotment Status; Issue Subscribed 173.53x; Check Latest GMP, Steps To Verify Status
The bidding window for Asston Pharmaceuticals SME IPO was open from July 9, 2025, to July 11, 2025. The basis of allotment will be finalised today, July 14, 2025. Here’s how you can check the IPO allotment status.
Step by Step Procedure to Check Asston Pharmaceuticals IPO Allotment Status Online On BSE
- Click here to visit the application status page.
- In Issue Type, “Equity.”
- In Issue Name, select “ Asston Pharmaceuticals LIMITED.”
- Enter your “Application No.” or “PAN No.”
- Click on “I am not a Robot.”
- Click “Submit.”
Procedure to Check Asston Pharmaceuticals IPO Allotment Status on Maashitla Securities (Registrar to the issue)
- Visit the Maashitla’s IPO allotment verification status page here.
- Select “ASSTON PHARMACEUTICALS LIMITED” under “Please select company.”
- Enter any of the following details.
- PAN
- Application Number
- Demat Account Number
- Click “Submit.”
IPO Details
Asston Pharmaceuticals IPO is a book-building issue of ₹27.56 crores, consisting entirely of a fresh issue of 22.41 lakh equity shares. The price band is set at ₹123 per share. The tentative listing on BSE is July 16, 2025.
Sobhagya Capital Options Ltd is the book-running lead manager, and Maashitla Securities is the registrar for the issue.
Use of Proceeds
The net proceeds from the fresh issue will be used towards:
- Set up a new manufacturing facility
- Working capital requirements
Asston Pharmaceuticals IPO - Overall Subscription Status
(July 11, 2025, end of the day)
|
Category |
Subscription (times) |
|
Qualified Institutional Investors (QIBs) |
85.76 |
|
Non-Institutional Investors |
261.67 |
|
Retail Individual Investors(RIIs) |
172.13 |
|
Total |
173.53 |
Click here to check out newly Listed IPOs
Asston Pharmaceuticals IPO GMP Details
As of 14 July 2025, Asston Pharmaceuticals IPO GMP stood at ₹30. The expected listing price is ₹153, i.e., a gain of 24.39%% per share.
|
Source: Business Standard Report dated 14 July, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Asston Pharmaceuticals Business Overview
Asston Pharmaceuticals is engaged in the development, production, and global distribution of high-quality pharmaceutical and nutraceutical products. Their product range includes a variety of dosage forms such as tablets, capsules, oral liquids, external applications (including creams, gels, ointments, and lotions), oral powders in the form of sachets and dry syrups.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here